Timing of pain pills after C-Section could reduce need for opioids
NCT ID NCT07102641
First seen Jun 26, 2026 · Last updated Sep 01, 2026 · Updated 3 times
Summary
This study compares two schedules for taking non-opioid pain relievers (acetaminophen and NSAIDs) after a cesarean delivery: taking them at different times (staggered) or at the same time (simultaneous). The goal is to see which approach better controls pain and reduces the need for stronger opioid drugs. The trial will enroll 825 women who have a C-section under regional anesthesia.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acetaminophen and NSAIDs (ketorolac/ibuprofen)
- What this could lead to
- If it works, this could establish a simple, non-opioid dosing schedule to improve pain control after C-sections.
- What could go wrong
- This is a Phase 4 trial comparing two common approaches, so the difference may be small. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 825 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \>/= 34 weeks gestation * Singleton pregnancy * Delivery via cesarean section under regional anesthesia Exclusion Criteria: * Contraindication to acetaminophen or NSAIDs * Current or history of opioid use or misuse * Intrauterine fetal demise * Major congenital anomaly * Conversion to general anesthesia intra-op or planned general anesthesia * Mid-line vertical skin incision * Receipt of intraoperative local analgesia such as Transversus Abdominis Plan (TAP) block or wound infiltration
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acetaminophen (D000082) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which painkiller mix works best after vasectomy?
- Can a pre-surgery paracetamol and tramadol combo beat fentanyl for day-case pain?
- Insulin eye drops put to the test for faster corneal healing
- Can a Longer-Lasting nerve block cut opioid use after spine surgery?
- Could a simple mineral calm the Body's Post-Surgery fire?
- Nanoparticle cleaning may calm pain after failed root canals in diabetic patients